Product
Intravitreal aflibercept
1 clinical trial
3 indications
Indication
Polypoidal Choroidal VasculopathyIndication
Choroidal NeovascularizationIndication
Age-related macular degenerationClinical trial
Tolerating Subretinal Fluid in Type 1 Macular Neovascularization and Polypoidal Choroidal Vasculopathy Treated Using AfliberceptStatus: Completed, Estimated PCD: 2023-05-31